Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials.

Keogh, Ruth H; Cosgriff, Rebecca; Andrinopoulou, Eleni-Rosalina; Brownlee, Keith G; Carr, Siobhán B; Diaz-Ordaz, Karla; Granger, Emily; Jewell, Nicholas P; Lewin, Alex; Leyrat, Clemence; +4 more... Schlüter, Daniela K; van Smeden, Maarten; Szczesniak, Rhonda D; Connett, Gary J; (2021) Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials. Thorax, 77 (9). pp. 873-881. ISSN 0040-6376 DOI: https://doi.org/10.1136/thoraxjnl-2020-216265

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/thoraxjnl-2020-216265

Abstract

Item Type Article
Faculty and Department Faculty of Epidemiology and Population Health > Dept of Medical Statistics
PubMed ID 34556554
Elements ID 166318

Share

Download

Filename: Keogh_etal_2021_Projecting-the-impact-of-triple.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar